New pain block combo could reduce opioid use in hip fracture seniors
NCT ID NCT07350044
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two approaches to pain control in elderly patients having hip fracture surgery: a standard femoral nerve block versus a femoral block plus an additional PENG block. The goal is to see if the combination reduces pain during spinal anesthesia positioning and lowers opioid use in the first 24 hours after surgery. The trial will enroll 68 participants aged 65 and older.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine (a numbing medication) given via nerve blocks
What this could lead to
If successful, this could show that combining two nerve blocks provides better pain relief and less need for opioids in elderly hip fracture patients.
What could go wrong
This is a small, early-stage trial with only 68 participants, so results may not apply to all patients. The added block may not provide significant benefit and carries its own small risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP FRACTURE SURGERIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ankara Bilkent City Hospital
RECRUITINGAnkara, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••